Sulfamidas's Blog

Just another WordPress.com site

REFERENCIAS CONSULTADAS noviembre 18, 2010

  • Guía de terapéutica antimicrobiana 2008. Mensa J, Gatell J Mª, Azanza J R, et al. Elsevier Doyma. 2008. ISBN 978-84-458-1813-8.
  • Goodman & Gilman. Las bases farmacológicas de la Terapéutica . Brunton L, Parker K. 2006. ISBN 970-10-5739-2.
  • Antibiotic essentials. Cunha BA. Physicians´Press 2007.
  • Kahn SB, et al. Effects of trimethoprim on folate metabolism in man. Clin PharmacolTherap 9: 550 – 560, 1968.
  • Degowin RL, Eppes RB, Carson PE, et al. The effects of diaphenylsulfone (DDS) against chloroquine-resistant Plasmodium falciparum.Bull World Health Organ 34: 671 – 681, 1966.
  • Vinnicombe HG, Derrick JP. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition. Biochem Biophys Res Commun 258: 752 – 757, 1999.
  • Alappan R, Perazella MA, and Buller GK. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med 124: 316 – 320, 1996.
  • Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology  clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 2001;144:339-46.
  • Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002;8:222-5.
  • Pradines B, Spiegel A, Rogier C, Tall A, Mosnier J, Fusai T, et al. Antibiotics for prophylaxis of Plasmodium falciparum infections: In vitro activity of doxycycline against Senegalese isolates. Am J Trop Med Hyg 2000;62: 82-5.
  • Skold O. Sulfonamide resistance: Mechanisms and trends. Drug Resist Updat 2000;3:155-60.
  • Huovinen P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis 2001;32:1608-14.
  • Greenwood D. Sulphonamides. En: Finch RG, Greenwood D, Norrby SR, Whitley RJ, editors. Antibiotic and chemotherapy. 8th ed. Philadelphia: Churchill Livingstone, 2003; p. 385-92.
  • Masters PA, O’Bryan TA, Zurlo J, Miller DQ, Joshi N. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med 2003;163:402-10.
  • Martin JN, Rose DA, Hadley K, Perdreau-Remington F, Lam PK, Gerberding JL. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis 1999;180:1809-18.
  • Freeman CD, Klutman NE, Lamp KC. Metronidazole. A therapeutic review and update. Drugs 1997;54:679-708.
 

Deja un comentario

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s

 
Seguir

Recibe cada nueva publicación en tu buzón de correo electrónico.